Newsroom

Sorted by: Latest

-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest Nasdaq-100 Moderate Buffer UCITS ETF - December 25.05.2026 QDEC.LN IE000GAKWFA7 450,002.00 USD 10,896,940.19 24.215  ...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Emerging Markets AlphaDEX UCITS ETF 25.05.2026 FEM IE00B8X9NX34 325,002.00 USD 16,547,936.72 50.916  ...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Indxx Europe Infrastructure UCITS ETF 25.05.2026 FTEI.LN IE000TIZ5AP4 200,002.00 EUR 4,201,426.03 21.007  ...
-

Simform Recognized in Everest Group’s Software Product Engineering Services PEAK Matrix® Assessment 2026

ORLANDO, Fla.--(BUSINESS WIRE)--Everest Group has recognized Simform as an Aspirant in the Software Product Engineering Services PEAK Matrix® Assessment 2026 - Global and EMEA. The recognition highlights Simform’s capabilities in helping organizations design, build, and scale modern digital products through product engineering expertise, cloud platforms, AI-driven engineering practices, and reusable accelerators. As enterprises modernize digital platforms and embed AI across products and develo...
-

NeoGenomics to Present New Research at ASCO Annual Meeting 2026

FORT MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics will showcase nine scientific abstracts at the 2026 ASCO Annual Meeting, May 29–June 2, 2026, in Chicago (booth #32130)....
-

Libretto Earns High Customer Satisfaction Ratings in 2026 Advisor Software Survey from T3 Technology Tools for Today and Inside Information

LOS ANGELES--(BUSINESS WIRE)--Libretto, the “total wealth” advice platform for RIAs and family offices, recently achieved high client satisfaction ratings in the 2026 T3 / Inside Information Software Survey1 – a widely referenced study in the wealthtech industry. Libretto earned the highest user satisfaction rating among firms with more than 1% market share in the Financial Planning Software and Portfolio Design Solutions categories. The results of the annual technology survey and report, produ...
-

American International College Partners with Sophia Learning to Expand Access to Education for Working Adult Learners

HERNDON, Va.--(BUSINESS WIRE)--Sophia Learning announces a new partnership with American International College (AIC)....
-

Mineros S.A. Identifies New High-Grade Vein System at the Nicaragua Property's Xiloa Target — 8.3 m at 17.3 g/t Au — Confirms High-Grade Continuity at Leticia with 1.2 m at 271.3 g/t Au

MEDELLÍN, Colombia--(BUSINESS WIRE)--Mineros S.A. (TSX:MSA, OTCQX: MNSAF, BVC:MINEROS) ("Mineros" or the "Company") is pleased to report initial results from its 2026 diamond drilling campaign at the Nicaragua Property. Results cover four target areas: Xiloa in the Pioneer Mine environs; the Leticia and Apoyo vein systems in the Porvenir Polymetallic District; La Reforma at the Pioneer Mine; and infill delineation at the Panamá Mine. HIGHLIGHTS New high-grade Vein System at Xiloa: 8.3 m at 17.3...
-

Ryan Specialty Announces $300 Million Increase to Share Repurchase Program

CHICAGO--(BUSINESS WIRE)--Ryan Specialty Holdings, Inc. (NYSE: RYAN) (“Ryan Specialty”), a leading international specialty insurance services firm, today announced that its Board of Directors on May 21, 2026 increased the authorization of its existing share repurchase program for shares of the Company’s Class A common stock by $300 million. As of May 22, 2026, the Company repurchased $260 million of Class A common stock in the second quarter, exhausting its prior authorization of $300 million....
-

Alkermes to Showcase Leadership in Psychiatry and Orexin Biology With New Data at the American Society of Clinical Psychopharmacology Annual Meeting

DUBLIN--(BUSINESS WIRE)--Alkermes plc (Nasdaq: ALKS) today announced plans to present clinical and real-world data related to the company’s psychiatry and orexin portfolios at the American Society of Clinical Psychopharmacology Annual Meeting, taking place May 26-29, 2026 in Miami. The poster presentations include data related to Alkermes’ proprietary commercial medicines, LYBALVI® (olanzapine and samidorphan) and ARISTADA® (aripiprazole lauroxil), and its pipeline of investigational orexin 2 r...